Treatment for glioblastoma (GBM)
Intended for US audiences only.

Learn how Optune® users and caregivers have put their lives on play

Over 7000 people have started Optune. Here, some of those users and their caregivers share their experiences with you through video and stories. Click through below to learn more.

Read Brian's Story

"I'm still working full time...and maintain some of my hobbies, like woodworking."

Click and read

Meet Dave

"It's very portable. That's what you want is portable. You don't want to be tied down."

Read Pat's Story

"My entire life, I have been a very independent woman, and my family is incredibly important
to me."

Click and read

Read JB's Story

"I've found we're all in a fight with something in our lives."

Click and read

Meet Sarah

"I love to be active. Work out. Work. I don't like to sit down until at least 4 or 5..."

Read Andrea's Story

"As Darrell's primary caregiver, I have to take care of my own health, too. I've learned to feed my soul."

Click and read
Reference:
  1. Novocure (NVCR) q4 2017 results. Presentation to investors, slide 6; February 22, 2018. https://www.novocure.com/investor-relations. Accessed June 13, 2018.

Connect with an Optune user

Sign up now

Find an Optune doctor

By ZIP code

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

Who should not use Optune?

Optune is not for everyone. Talk to your doctor if you have:

Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.

What should I know before using Optune?

Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure™, the maker of Optune.

What are the possible side effects of Optune?

Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.

The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

Talk to your doctor if you have any of these side effects or questions.


Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.


On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals.

What is Optune approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.